Zacks: Analysts Expect Ceridian HCM Holding Inc. (NYSE:CDAY) to Post $0.08 EPS

Brokerages expect Ceridian HCM Holding Inc. (NYSE:CDAY – Get Rating) to report earnings of $0.08 per share for the current fiscal quarter, according to Zacks. Six analysts have provided estimates for Ceridian HCM’s earnings, with the lowest EPS estimate coming in at $0.06 and the highest estimate coming in at $0.13. Ceridian HCM reported earnings per share of $0.09 during the same quarter last year, which indicates a negative year-over-year growth rate of 11.1%. The company is scheduled to announce its next earnings report after the market closes on Monday, January 1st.

On average, analysts expect that Ceridian HCM will report full year earnings of $0.37 per share for the current year, with EPS estimates ranging from $0.29 to $0.55. For the next fiscal year, analysts anticipate that the firm will post earnings of $0.58 per share, with EPS estimates ranging from $0.43 to $0.76. Zacks’ EPS averages are an average based on a survey of analysts that cover Ceridian HCM.

Ceridian HCM (NYSE:CDAY – Get Rating) last issued its earnings results on Wednesday, February 9th. The company reported ($0.14) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.12) by ($0.02). The business had revenue of $282.10 million during the quarter, compared to analyst estimates of $274.98 million. Ceridian HCM had a negative net margin of 7.36% and a negative return on equity of 2.73%. During the same period in the prior year, the business posted ($0.02) EPS.

CDAY has been the topic of a number of research analyst reports. Wolfe Research downgraded Ceridian HCM from a “peer perform” rating to an “underperform” rating in a report on Friday, February 11th. Piper Sandler reduced their target price on Ceridian HCM from $105.00 to $85.00 and set a “neutral” rating on the stock in a report on Thursday, February 10th. Deutsche Bank Aktiengesellschaft reduced their target price on Ceridian HCM from $110.00 to $105.00 and set a “buy” rating on the stock in a report on Thursday, February 10th. Credit Suisse Group started coverage on Ceridian HCM in a report on Wednesday, March 23rd. They set an “outperform” rating and a $85.00 price objective on the stock. Finally, Mizuho cut their price objective on Ceridian HCM from $140.00 to $100.00 and set a “buy” rating on the stock in a report on Friday, January 28th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $96.45.

In other news, EVP Christopher R. Armstrong sold 3,891 shares of Ceridian HCM stock in a transaction dated Wednesday, February 9th. The stock was sold at an average price of $79.48, for a total value of $309,256.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP William Everett Mcdonald sold 1,225 shares of Ceridian HCM stock in a transaction dated Wednesday, March 9th. The stock was sold at an average price of $62.49, for a total value of $76,550.25. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 13,353 shares of company stock valued at $900,537. 3.90% of the stock is owned by corporate insiders.

Hedge funds have recently bought and sold shares of the company. Quent Capital LLC bought a new position in shares of Ceridian HCM in the 4th quarter worth about $36,000. Ellevest Inc. increased its position in Ceridian HCM by 311.5% in the 4th quarter. Ellevest Inc. now owns 395 shares of the company’s stock valued at $41,000 after buying an additional 299 shares in the last quarter. O Shaughnessy Asset Management LLC increased its position in Ceridian HCM by 48.8% in the 3rd quarter. O Shaughnessy Asset Management LLC now owns 561 shares of the company’s stock valued at $63,000 after buying an additional 184 shares in the last quarter. Fifth Third Bancorp increased its position in Ceridian HCM by 65.9% in the 4th quarter. Fifth Third Bancorp now owns 793 shares of the company’s stock valued at $83,000 after buying an additional 315 shares in the last quarter. Finally, US Bancorp DE increased its position in Ceridian HCM by 89.1% in the 3rd quarter. US Bancorp DE now owns 968 shares of the company’s stock valued at $110,000 after buying an additional 456 shares in the last quarter.

Shares of CDAY stock opened at $58.13 on Friday. The stock’s fifty day moving average price is $66.19 and its two-hundred day moving average price is $90.86. The company has a market cap of $8.84 billion, a PE ratio of -116.26 and a beta of 1.47. Ceridian HCM has a fifty-two week low of $57.91 and a fifty-two week high of $130.37. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 1.11.

About Ceridian HCM (Get Rating)

Ceridian HCM Holding Inc, together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market.

Featured Articles